Kardioklinika - Company finances
|
EUR
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | - | 13,426 | 8,250 | 17,450 | 15,250 | 20,228 |
| Profit before tax | - | - | - | - | 565 | 3,150 |
| Net profit | -100 | -20,620 | -10,137 | 7,548 | 565 | 3,150 |
| Equity | 2,650 | -17,970 | -28,107 | -17,109 | -16,544 | -13,394 |
| Liabilities | 33,186 | 38,959 | 55,647 | 50,276 | 55,200 | 61,073 |
| Non-current assets | 0 | 0 | 4,708 | 4,713 | 3,311 | 2,070 |
| Current assets | 35,836 | 17,448 | 18,179 | 28,454 | 35,345 | 45,336 |
| Total assets | 35,836 | 17,448 | 22,887 | 33,167 | 38,656 | 47,406 |
|
Taxes paid
|
||||||
| STI taxes | - | - | - | 9,960 | 213 | 379 |
| Social insurance contributions | - | - | - | 10,482 | - | - |
|
Financial indicators
|
||||||
| Revenue change y/y | - | - | -38.6% | +111.5% | -12.6% | +32.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -0.3% | -118.2% | -44.3% | 22.8% | 1.5% | 6.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -3.8% | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | -153.6% | -122.9% | 43.3% | 3.7% | 15.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | 3.7% | 15.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 12.5 | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 3,502 | 1,650 | 3,739 | 3,813 | 5,057 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Kardioklinika - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-02-18 | 2026-03-04 | 0.05 |
| 2026-01-21 | 2026-02-12 | 0.05 |
| 2025-10-16 | 2025-10-19 | 61.87 |
| 2025-01-16 | 2025-02-16 | 0.01 |
| 2025-01-02 | 2025-01-07 | 0.01 |
| 2024-12-22 | 2024-12-31 | 0.01 |
| 2024-12-17 | 2024-12-20 | 0.01 |
| 2024-11-18 | 2024-12-12 | 0.01 |
| 2024-10-24 | 2024-11-14 | 0.01 |
| 2024-08-19 | 2024-09-08 | 0.02 |
| 2024-07-24 | 2024-08-11 | 0.02 |
| 2023-02-24 | 2023-03-13 | 2.63 |
| 2022-05-17 | 2022-06-13 | 0.01 |
| 2022-04-19 | 2022-05-15 | 0.01 |
Kardioklinika - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Kardioklinika is: 5 €
| From | To | Overdue, € |
|---|---|---|
| 2026-02-21 | 2026-09-02 | 4.96 |
| 2025-02-20 | 2026-02-16 | 4.96 |
| 2024-02-17 | 2025-02-17 | 4.96 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Kardioklinika, UAB (code 134565559) is a Private Limited Liability Company engaged in medical specialists activities. In the latest financial year 2025, the company generated revenue of €20.2K and net profit of €3.1K, resulting in a profit margin of 15.6%. Revenue increased by 32.6% year on year and by 15.9% over two years, showing a recovery after the weaker 2024 result. In 2024, revenue was €15.2K and net profit €565, while in 2023 the company reported €17.4K in revenue and €7.5K in net profit. Profitability therefore weakened sharply in 2024 before improving in 2025. At the balance-sheet level, total assets reached €47.4K in 2025, compared with liabilities of €61.1K and negative equity of €13.4K. Short-term assets of €45.3K made up most of the asset base, while long-term assets were €2.1K. Asset turnover stood at 0.43x and return on assets at 6.6%. Revenue per employee was €5.1K, with profit per employee of €788.